WARRINGTON, Pa., Nov. 27, 2024 (GLOBE NEWSWIRE) — Windtree Therapeutics, Inc. (“Windtree” or “the Company”) (NasdaqCM: WINT), a biotechnology company focused on advancing early and late-stage innovative therapies for critical conditions, today reported financial results for the third quarter ended September 30, 2024 and provided key business updates.
GlobeNewswire,is one of the world's largest newswire distribution networks, specializing in the delivery of corporate press releases financial disclosures and multimedia content to the media, investment community, individual investors and the general public.
Latest posts by GlobeNewswire (see all)
- Pennsylvania Skill, powered by Pace-O-Matic, Responds to Commonwealth Court Ruling in Favor of Skill Games - December 7, 2024
- Admirals Group AS Announces a Sale of its Australian Subsidiary - December 7, 2024
- ROSEN, A GLOBALLY RESPECTED LAW FIRM, Encourages TMC the metals company Inc. Investors to Secure Counsel Before Important Deadline in Securities Class Action – TMC - December 7, 2024
